Home  >  News
Eppen_Multi_Oct24
you can get e-magazine links on WhatsApp. Click here
News
  Merck’s phase 3 KEYNOTE-689 trial of anti-PD-1 therapy, Keytruda to treat LA-HNSCC meets its primary endpoint of event-free survival,   October 09, 2024
  US FDA grants marketing authorization to Healgen Rapid Check Covid-19/Flu A&B antigen test,   October 09, 2024
  Boehringer gets US FDA breakthrough therapy designation and initiates two phase III trials in MASH for survodutide,   October 09, 2024
  Immunovia acquires all blood samples required to clinically validate its next-generation test for pancreatic cancer,   October 08, 2024
  BizDateUp leads US$ 1 million pre-IPO funding round in Sorich, a pharma packaging startup,   October 08, 2024
  IMU Biosciences joins ground-breaking UK research consortium investigating patient response to cancer immunotherapies,   October 08, 2024
  Lombardy, the best location for pharma manufacturing in Europe,   October 08, 2024
  NTC partners with Silgan Dispensing Systems to commercialize a set of new NTC proprietary eye drops with innovative Silgan technology Iridya,   October 08, 2024
  Biocon Biologics’ highlights pathways to increase adoption of biosimilars in LMICs,   October 08, 2024
  BerGenBio announces safety data from phase 1b portion of BGBC016 study in first-line NSCLC,   October 08, 2024
  AstraZeneca inks license agreement with CSPC Pharma to develop an early stage, novel small molecule Lipoprotein (a),   October 08, 2024
  Dräger India gives a boost to pre-natal care with its new TN300 Open Warmer BabyRoo,   October 08, 2024
  Gleneagles Hospitals, Parel, Mumbai appoints Dr Bipin Chevale as CEO,   October 08, 2024
  OneSource, a multimodal global specialty pharma CDMO of Strides Group unveils new brand identity at CPHI, Milan,   October 08, 2024
  GE HealthCare completes phase I clinical development programme for a first-of-its-kind manganese-based macrocyclic MRI contrast agent,   October 08, 2024
  Lesaffre strengthens research, development & innovation with the acquisition of French start-up Altar,   October 08, 2024
  Hansa Biopharma announces positive results from NICE-01 trial of next generation IgG-cleaving molecule, HNSA-5487,   October 08, 2024
  MEDICAL JAPAN 2024 to be held in Makuhari Messe, Japan from October 9 to 11,   October 08, 2024
  AstraZeneca’s BATURA phase IIIb trial of Airsupra in patients with intermittent or mild persistent asthma meets primary endpoint,   October 08, 2024
  Study shows new imaging technique accurately detects aggressive kidney cancer,   October 07, 2024

  • Results Found: 115092
  • 1
    •  
  • 2
    •  
  • 3
    •  
  • 4
    •  
  • 5
    •  
  • Go to
  • Total Number of Pages: 5755
 Back
 
avians24_PB
BTS_2024
cphi_ww24
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram